COREG Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Coreg, and when can generic versions of Coreg launch?
Coreg is a drug marketed by Waylis Therap and is included in two NDAs. There is one patent protecting this drug.
The generic ingredient in COREG is carvedilol phosphate. There are thirty-seven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the carvedilol phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Coreg
A generic version of COREG was approved as carvedilol phosphate by SUN PHARM INDUSTRIES on October 25th, 2017.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for COREG?
- What are the global sales for COREG?
- What is Average Wholesale Price for COREG?
Summary for COREG
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 145 |
Patent Applications: | 4,472 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for COREG |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for COREG |
What excipients (inactive ingredients) are in COREG? | COREG excipients list |
DailyMed Link: | COREG at DailyMed |
![COREG drug patent expirations Drug patent expirations by year for COREG](/p/graph/s/t/COREG-patent-expirations.png)
![Drug Prices for COREG](/p/graph/drug-price/COREG.png)
![Drug Sales Revenue Trends for COREG](/p/graph/drug-sales-revenues/COREG.png)
Pharmacology for COREG
Drug Class | alpha-Adrenergic Blocker beta-Adrenergic Blocker |
Mechanism of Action | Adrenergic alpha-Antagonists Adrenergic beta1-Antagonists Adrenergic beta2-Antagonists |
US Patents and Regulatory Information for COREG
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Waylis Therap | COREG | carvedilol | TABLET;ORAL | 020297-004 | May 29, 1997 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Waylis Therap | COREG CR | carvedilol phosphate | CAPSULE, EXTENDED RELEASE;ORAL | 022012-003 | Oct 20, 2006 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||
Waylis Therap | COREG | carvedilol | TABLET;ORAL | 020297-001 | Sep 14, 1995 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Waylis Therap | COREG CR | carvedilol phosphate | CAPSULE, EXTENDED RELEASE;ORAL | 022012-004 | Oct 20, 2006 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||
Waylis Therap | COREG | carvedilol | TABLET;ORAL | 020297-003 | Sep 14, 1995 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for COREG
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Waylis Therap | COREG | carvedilol | TABLET;ORAL | 020297-002 | Sep 14, 1995 | ⤷ Sign Up | ⤷ Sign Up |
Waylis Therap | COREG | carvedilol | TABLET;ORAL | 020297-003 | Sep 14, 1995 | ⤷ Sign Up | ⤷ Sign Up |
Waylis Therap | COREG | carvedilol | TABLET;ORAL | 020297-003 | Sep 14, 1995 | ⤷ Sign Up | ⤷ Sign Up |
Waylis Therap | COREG | carvedilol | TABLET;ORAL | 020297-004 | May 29, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Waylis Therap | COREG | carvedilol | TABLET;ORAL | 020297-003 | Sep 14, 1995 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for COREG
See the table below for patents covering COREG around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Austria | A276279 | ⤷ Sign Up | |
Slovenia | 0808162 | ⤷ Sign Up | |
Netherlands | 930110 | ⤷ Sign Up | |
Mexico | 9203380 | DERIVADOS DE CARBAZOLIL-(4)-OXI-PROPANOLAMINA Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN. | ⤷ Sign Up |
Hungary | 9900773 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |